NuCana plc Releases 2024 UK Annual Report
Ticker: NCNA · Form: 6-K · Filed: Jun 5, 2025 · CIK: 1709626
| Field | Detail |
|---|---|
| Company | Nucana PLC (NCNA) |
| Form Type | 6-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, filing
TL;DR
NuCana plc dropped its 2024 UK Annual Report on June 5th. Check it for the deets.
AI Summary
On June 5, 2025, NuCana plc published its 2024 UK Annual Report. The report covers the company's performance for the year ended December 31, 2024. NuCana plc is a pharmaceutical preparations company based in Edinburgh, United Kingdom.
Why It Matters
This filing provides shareholders and the public with a comprehensive overview of NuCana plc's financial and operational performance for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material events or significant financial changes.
Key Players & Entities
- NuCana plc (company) — Registrant
- June 5, 2025 (date) — Filing Date
- 2024 UK Annual Report (document) — Report Published
- December 31, 2024 (date) — Fiscal Year End
- Edinburgh, United Kingdom (location) — Company Headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the publication of NuCana plc's 2024 UK Annual Report.
When was the 2024 UK Annual Report published?
The 2024 UK Annual Report was published on June 5, 2025.
What period does the 2024 UK Annual Report cover?
The 2024 UK Annual Report covers the year ended December 31, 2024.
What is NuCana plc's principal executive office address?
NuCana plc's principal executive office is located at 3 Lochside Way, Edinburgh EH12 9DT, United Kingdom.
Does NuCana plc file annual reports under Form 20-F or Form 40-F?
NuCana plc indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 5, 2025 regarding NuCana plc (NCNA).